Thomas Glück

2.1k total citations
36 papers, 1.4k citations indexed

About

Thomas Glück is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Thomas Glück has authored 36 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 12 papers in Infectious Diseases and 6 papers in Surgery. Recurrent topics in Thomas Glück's work include Sepsis Diagnosis and Treatment (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Pneumonia and Respiratory Infections (5 papers). Thomas Glück is often cited by papers focused on Sepsis Diagnosis and Treatment (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Pneumonia and Respiratory Infections (5 papers). Thomas Glück collaborates with scholars based in Germany, Canada and United States. Thomas Glück's co-authors include David Dreisinger, Jianming Lü, Bernd Salzberger, Gerd Schmitz, Steven M. Opal, Gerhard Liebisch, G. Rothe, Dieter Fröhlich, Boris Ehrenstein and Jürgen Schölmerich and has published in prestigious journals such as Clinical Infectious Diseases, Annals of the New York Academy of Sciences and The Journal of Infectious Diseases.

In The Last Decade

Thomas Glück

35 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Glück Germany	20	386	303	248	223	137	36	1.4k
Fang Yang China	25	157 0.4×	620 2.0×	198 0.8×	234 1.0×	112 0.8×	141	1.8k
Dan Peng China	22	236 0.6×	626 2.1×	145 0.6×	84 0.4×	133 1.0×	80	1.4k
Abdul Malik Saudi Arabia	22	277 0.7×	306 1.0×	86 0.3×	47 0.2×	81 0.6×	139	1.5k
Yu‐Yao Huang Taiwan	26	184 0.5×	456 1.5×	99 0.4×	92 0.4×	409 3.0×	136	2.2k
Shuquan Wei China	18	95 0.2×	235 0.8×	488 2.0×	216 1.0×	51 0.4×	46	1.4k
Seung Heon Lee South Korea	20	421 1.1×	193 0.6×	430 1.7×	70 0.3×	189 1.4×	105	1.4k
Ming‐Ju Wu Taiwan	24	278 0.7×	267 0.9×	108 0.4×	132 0.6×	401 2.9×	152	2.0k
Jae Yeol Kim South Korea	26	419 1.1×	764 2.5×	245 1.0×	575 2.6×	283 2.1×	134	2.7k
Yuanyuan Li China	30	249 0.6×	490 1.6×	498 2.0×	59 0.3×	234 1.7×	112	2.5k
Songmei Wang China	21	171 0.4×	272 0.9×	283 1.1×	49 0.2×	72 0.5×	85	1.2k

Countries citing papers authored by Thomas Glück

Since Specialization

Citations

This map shows the geographic impact of Thomas Glück's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Glück with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Glück more than expected).

Fields of papers citing papers by Thomas Glück

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Glück. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Glück. The network helps show where Thomas Glück may publish in the future.

Co-authorship network of co-authors of Thomas Glück

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Glück. A scholar is included among the top collaborators of Thomas Glück based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Glück. Thomas Glück is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vogel, Matthias, Annelie Plentz, Josef Köstler, et al.. (2022). Omicron’s binding to sotrovimab, casirivimab, imdevimab, CR3022, and sera from previously infected or vaccinated individuals. iScience. 25(4). 104076–104076. 25 indexed citations

Köstler, Josef, Bernd Salzberger, Ralf Wagner, et al.. (2022). Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects. Infection. 50(6). 1475–1481. 11 indexed citations

Salzberger, Bernd, Thomas Glück, & Boris Ehrenstein. (2020). Successful containment of COVID-19: the WHO-Report on the COVID-19 outbreak in China. Infection. 48(2). 151–153. 114 indexed citations

Erhardt, Andreas, Alexander Link, Philipp Ehlermann, et al.. (2019). The impact of technical and clinical factors on fecal microbiota transfer outcomes for the treatment of recurrent Clostridioides difficile infections in Germany. United European Gastroenterology Journal. 7(5). 716–722. 17 indexed citations

Glück, Thomas. (2016). Infection Risk with Corticosteroid Therapy. Journal watch. 2016. 1 indexed citations

Lü, Jianming, David Dreisinger, & Thomas Glück. (2016). Electrolytic manganese metal production from manganese carbonate precipitate. Hydrometallurgy. 161. 45–53. 54 indexed citations

Glück, Thomas. (2013). What Is the True Incidence of Severe Sepsis in the U.S.. Journal watch. 2013.

Glück, Thomas. (2011). Updated Guidelines for the Programmatic Management of Drug-Resistant TB. Journal watch. 2011. 2 indexed citations

Glück, Thomas. (2011). Long-Term Prognosis of. Journal watch. 2011. 4 indexed citations

10.

Barlage, Stefan, Carsten Gnewuch, Gerhard Liebisch, et al.. (2009). Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation. Intensive Care Medicine. 35(11). 1877–1885. 112 indexed citations

11.

Neugebauer, Hermann, Pia Hartmann, Thomas Glück, et al.. (2008). Bacterial translocation increases phagocytic activity of polymorphonuclear leucocytes in portal hypertension: priming independent of liver cirrhosis. Liver International. 28(8). 1149–1157. 28 indexed citations

12.

Langgartner, Julia, et al.. (2008). Pharmacokinetics of meropenem during intermittent and continuous intravenous application in patients treated by continuous renal replacement therapy. Intensive Care Medicine. 34(6). 1091–1096. 46 indexed citations

13.

Glück, Thomas. (2007). Efficacy of Human Monoclonal Antibodies Against H5N1 Influenza. Journal watch. 2007. 1 indexed citations

14.

Glück, Thomas. (2007). Antimicrobial Resistance in. Journal watch. 2007. 34 indexed citations

15.

Straub, Rainer H., Georg Pongratz, Claudia Weidler, et al.. (2005). Ablation of the Sympathetic Nervous System Decreases Gram‐Negative and Increases Gram‐Positive Bacterial Dissemination: Key Roles for Tumor Necrosis Factor/Phagocytes and Interleukin‐4/Lymphocytes. The Journal of Infectious Diseases. 192(4). 560–572. 45 indexed citations

16.

Reinhart, Konrad, Thomas Glück, Jack J. M. Ligtenberg, et al.. (2004). CD14 receptor occupancy in severe sepsis: Results of a phase I clinical trial with a recombinant chimeric CD14 monoclonal antibody (IC14)*. Critical Care Medicine. 32(5). 1100–1108. 57 indexed citations

17.

Drobnik, Wolfgang, Gerhard Liebisch, Dieter Fröhlich, et al.. (2003). Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients. Journal of Lipid Research. 44(4). 754–761. 269 indexed citations

18.

Opal, Steven M. & Thomas Glück. (2003). Endotoxin as a drug target. Critical Care Medicine. 31(Supplement). S57–S64. 82 indexed citations

19.

Pongratz, Georg, B. Zietz, Thomas Glück, Jürgen Schölmerich, & Rainer H. Straub. (2002). Corticotropin‐Releasing Factor Modulates Cardiovascular and Pupillary Autonomic Reflexes in Man. Annals of the New York Academy of Sciences. 966(1). 373–383. 5 indexed citations

20.

Glück, Thomas, et al.. (2000). Autonomic neuropathy in patients with HIV: Course, impact of disease stage, and medication. Clinical Autonomic Research. 10(1). 17–22. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact